351 related articles for article (PubMed ID: 17135343)
1. The hypolipidemic agent guggulsterone regulates the expression of human bile salt export pump: dominance of transactivation over farsenoid X receptor-mediated antagonism.
Deng R; Yang D; Radke A; Yang J; Yan B
J Pharmacol Exp Ther; 2007 Mar; 320(3):1153-62. PubMed ID: 17135343
[TBL] [Abstract][Full Text] [Related]
2. Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor.
Deng R; Yang D; Yang J; Yan B
J Pharmacol Exp Ther; 2006 Apr; 317(1):317-25. PubMed ID: 16371446
[TBL] [Abstract][Full Text] [Related]
3. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor.
Ananthanarayanan M; Balasubramanian N; Makishima M; Mangelsdorf DJ; Suchy FJ
J Biol Chem; 2001 Aug; 276(31):28857-65. PubMed ID: 11387316
[TBL] [Abstract][Full Text] [Related]
4. Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump.
Cui J; Huang L; Zhao A; Lew JL; Yu J; Sahoo S; Meinke PT; Royo I; Pelaez F; Wright SD
J Biol Chem; 2003 Mar; 278(12):10214-20. PubMed ID: 12525500
[TBL] [Abstract][Full Text] [Related]
5. Hypolipidemic agent Z-guggulsterone: metabolism interplays with induction of carboxylesterase and bile salt export pump.
Yang D; Yang J; Shi D; Xiao D; Chen YT; Black C; Deng R; Yan B
J Lipid Res; 2012 Mar; 53(3):529-539. PubMed ID: 22246918
[TBL] [Abstract][Full Text] [Related]
6. Guggulsterone antagonizes farnesoid X receptor induction of bile salt export pump but activates pregnane X receptor to inhibit cholesterol 7alpha-hydroxylase gene.
Owsley E; Chiang JY
Biochem Biophys Res Commun; 2003 Apr; 304(1):191-5. PubMed ID: 12705905
[TBL] [Abstract][Full Text] [Related]
7. Liver receptor homolog 1 transcriptionally regulates human bile salt export pump expression.
Song X; Kaimal R; Yan B; Deng R
J Lipid Res; 2008 May; 49(5):973-84. PubMed ID: 18270374
[TBL] [Abstract][Full Text] [Related]
8. Bile salt excretory pump: biology and pathobiology.
Suchy FJ; Ananthanarayanan M
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
[TBL] [Abstract][Full Text] [Related]
9. Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450.
Schuetz EG; Strom S; Yasuda K; Lecureur V; Assem M; Brimer C; Lamba J; Kim RB; Ramachandran V; Komoroski BJ; Venkataramanan R; Cai H; Sinal CJ; Gonzalez FJ; Schuetz JD
J Biol Chem; 2001 Oct; 276(42):39411-8. PubMed ID: 11509573
[TBL] [Abstract][Full Text] [Related]
10. Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters.
Hoeke MO; Plass JR; Heegsma J; Geuken M; van Rijsbergen D; Baller JF; Kuipers F; Moshage H; Jansen PL; Faber KN
Hepatology; 2009 Jan; 49(1):151-9. PubMed ID: 19111018
[TBL] [Abstract][Full Text] [Related]
11. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity.
Yu J; Lo JL; Huang L; Zhao A; Metzger E; Adams A; Meinke PT; Wright SD; Cui J
J Biol Chem; 2002 Aug; 277(35):31441-7. PubMed ID: 12052824
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of the rat bile salt export pump gene promoter.
Gerloff T; Geier A; Roots I; Meier PJ; Gartung C
Eur J Biochem; 2002 Jul; 269(14):3495-503. PubMed ID: 12135489
[TBL] [Abstract][Full Text] [Related]
13. Identification of 15d-PGJ2 as an antagonist of farnesoid X receptor: molecular modeling with biological evaluation.
Xu X; Lu Y; Chen L; Chen J; Luo X; Shen X
Steroids; 2013 Sep; 78(9):813-22. PubMed ID: 23707573
[TBL] [Abstract][Full Text] [Related]
14. Dietary cholesterol stimulates CYP7A1 in rats because farnesoid X receptor is not activated.
Xu G; Pan LX; Li H; Shang Q; Honda A; Shefer S; Bollineni J; Matsuzaki Y; Tint GS; Salen G
Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G730-5. PubMed ID: 14684380
[TBL] [Abstract][Full Text] [Related]
15. 1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor.
Honjo Y; Sasaki S; Kobayashi Y; Misawa H; Nakamura H
J Endocrinol; 2006 Mar; 188(3):635-43. PubMed ID: 16522742
[TBL] [Abstract][Full Text] [Related]
16. Disrupted coordinate regulation of farnesoid X receptor target genes in a patient with cerebrotendinous xanthomatosis.
Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Hirayama T; Tint GS; Doy M; Shefer S
J Lipid Res; 2005 Feb; 46(2):287-96. PubMed ID: 15576845
[TBL] [Abstract][Full Text] [Related]
17. A natural product that lowers cholesterol as an antagonist ligand for FXR.
Urizar NL; Liverman AB; Dodds DT; Silva FV; Ordentlich P; Yan Y; Gonzalez FJ; Heyman RA; Mangelsdorf DJ; Moore DD
Science; 2002 May; 296(5573):1703-6. PubMed ID: 11988537
[TBL] [Abstract][Full Text] [Related]
18. Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump.
Plass JR; Mol O; Heegsma J; Geuken M; Faber KN; Jansen PL; Müller M
Hepatology; 2002 Mar; 35(3):589-96. PubMed ID: 11870371
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of guggul and its constituent guggulsterone: cardiovascular benefits.
Deng R
Cardiovasc Drug Rev; 2007; 25(4):375-90. PubMed ID: 18078436
[TBL] [Abstract][Full Text] [Related]
20. The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor.
Frankenberg T; Miloh T; Chen FY; Ananthanarayanan M; Sun AQ; Balasubramaniyan N; Arias I; Setchell KD; Suchy FJ; Shneider BL
Hepatology; 2008 Dec; 48(6):1896-905. PubMed ID: 18668687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
